Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults

References

• Drossman DA. Introduction. The Rome Foundation and Rome III. Neurogastroenterol Motil 2007;19:783–6.
   PubMed Web of Science ®Google Scholar
• Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17:29–34.
   PubMed Web of Science ®Google Scholar
• Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007;133:799–807.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569–80.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165–77.
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Heaton KW. The metabolic consequences of slow colonic transit. Am J Gastroenterol 1999;94:2010–16.
   PubMedGoogle Scholar
• Williams MD, Ha CY, Ciorba MA. Probiotics as Therapy in Gastroenterology: A Study of Physician Opinions and Recommendations. J Clin Gastroenterol 2010;44:631–6.
   Google Scholar
• Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients. Am J Gastroenterol 2010;105:1636–41.
   Google Scholar
• Chen CC, Kong MS, Lai MW, Chao HC, Chang KW, Chen SY, Probiotics have clinical, microbiologic, and immunologic efficacy in acute infectious diarrhea. Pediatr Infect Dis J 2010;29:135–8.
   PubMed Web of Science ®Google Scholar
• Shanahan F. Gut microbes: from bugs to drugs. Am J Gastroenterol 2010;105:275–9.
   PubMedGoogle Scholar
• Bixquert Jimenez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Rev Esp Enferm Dig 2009;101:553–64.
   PubMed Web of Science ®Google Scholar
• Sanders ME. Summary of probiotic activities of Bifidobacterium lactis HN019. J Clin Gastroenterol 2006;40:776–83.
   PubMedGoogle Scholar
• Ahmed M, Prasad J, Gill H, Stevenson L, Gopal P. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J Nutr Health Aging 2007;11:26–31.
   PubMed Web of Science ®Google Scholar
• Bouchoucha M, Thomas SR. Error analysis of classic colonic transit time estimates. Am J Physiol Gastrointest Liver Physiol 2000;279:G520–7.
   PubMedGoogle Scholar
• Bouchoucha M, Devroede G, Faye A, Le Toumelin P, Arhan P, Arsac M. Colonic response to food in constipation. Int J Colorectal Dis 2006;21:826–33.
   PubMedGoogle Scholar
• Bouchoucha M, Devroede G, Arhan P, Strom B, Weber J, Cugnenc PH, What is the meaning of colorectal transit time measurement? Dis Colon Rectum 1992;35:773–82.
   PubMed Web of Science ®Google Scholar
• Heydarian F, Kianifar HR, Ahanchian H, Khakshure A, Seyedi J, Moshirian D. A comparison between traditional yogurt and probiotic yogurt in non-inflammatory acute gastroenteritis. Saudi Med J 2010;31:280–3.
   PubMedGoogle Scholar
• Kita F, Shibata Y, Yorifuji T, Nakahata T, Kawakami J, Kawakami K. Prescription trends for treatment of paediatric gastroenteritis at a Japanese hospital between 1997 and 2007. J Clin Pharm Ther 2010;35:87–92.
   PubMedGoogle Scholar
• Szajewska H, Skorka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther 2009;30:960–1.
   PubMed Web of Science ®Google Scholar
• Salvatore S, Hauser B, Devreker T, Vieira MC, Luini C, Arrigo S, Probiotics and zinc in acute infectious gastroenteritis in children: are they effective? Nutrition 2007;23:498–506.
   PubMedGoogle Scholar
• Vandenplas Y, Benninga M. Probiotics and functional gastrointestinal disorders in children. J Pediatr Gastroenterol Nutr 2009;48(Suppl 2):S107–9.
   PubMedGoogle Scholar
• Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M, Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002;16:587–93.
   PubMed Web of Science ®Google Scholar
• Chassany O, Bonaz B, Bruley DESVS, Bueno L, Cargill G, Coffin B, Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2007;25:1115–23.
   PubMedGoogle Scholar
• Jafri W, Yakoob J, Hussain S, Jafri N, Islam M. Phloroglucinol in irritable bowel syndrome. J Pak Med Assoc 2006;56:5–8.
   PubMedGoogle Scholar
• Salminen S, Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol Suppl 1997;222:45–8.
   PubMedGoogle Scholar
• Muller-Lissner SA. Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis. Br Med J (Clin Res Ed) 1988;296:615–17.
   PubMed Web of Science ®Google Scholar
• Cook IJ, Irvine EJ, Campbell D, Shannon S, Reddy SN, Collins SM. Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study. Gastroenterology 1990;98:66–72.
   PubMed Web of Science ®Google Scholar
• Lambert JP, Brunt PW, Mowat NA, Khin CC, Lai CK, Morrison V, The value of prescribed ‘high-fibre’ diets for the treatment of the irritable bowel syndrome. Eur J Clin Nutr 1991;45:601–9.
   PubMedGoogle Scholar
• Dekker JW, Wickens K, Black PN, Stanley TV, Mitchell EA, Fitzharris P, Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019 in human infants aged 0–2 years. Int Dairy J 2009;19:149–54.
   Web of Science ®Google Scholar